Worldwide, over one billion people suffer from neurodisorders, which often require multiple forms of long-term treatment. BrainQ’s founders set out to create a groundbreaking in-home, cloud-based solution that would promote neurorecovery while alleviating the burden on patients and their loved ones. BrainQ’s device uses non-invasive, frequency-tuned extremely low frequency and low intensity electromagnetic fields (ELF-EMF) with aim of promoting neurological recovery in the central nervous system (CNS). The artificial intelligence (AI)-powered device tailors the electromagnetic field characteristics to suit each patient.
Why we invested
Neurological disorders affect more than one billion people worldwide and create a significant burden on society. Stroke in particular is one of the world’s leading causes of death and is a major cause of disability for adults. BrainQ is a first mover that has also been granted an expedited time to market by the FDA. They are innovating in a large market that is ~10X the size of existing solutions used in stroke care due to the product’s robust use cases and superior efficacy in reducing disability in stroke victims.
In the founder’s words
Immediately I could see that the first thing that Hanaco looks at and cares about is the founder—not just the numbers. Coming from the intersection of life science and technology, investors are generally obsessed with data.
When I met Hanaco, the first thing I saw was that they cared about my vision, my aspirations, my leadership skills, my ability to run the company, and how I see its future. This meant a lot because it’s so rare in my world.
The other thing I really love about Hanaco is how humble they are. Hanaco trusts you to do your job. They invested in you because of you. They are partners and advisers. They help you wherever you need it, but it’s your journey and they respect your decisions. ” — Yotam Drechsler, Founder, BrainQ